{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:59:21Z","timestamp":1791223161158,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009242","name":"Direction generale de l'offre de soins","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.sapharm.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:57:44Z","timestamp":1782889064000},"page":"1112-1118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst\u2019 open-label, multicenter, randomized, controlled, cluster study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-4717","authenticated-orcid":false,"given":"Arthur","family":"Piraux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Parot-Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anth\u00e9a","family":"Loiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Ramond-Roquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sapharm.2026.06.009_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0002-2012","article-title":"Clinical presentations and epidemiology of urinary tract infections","volume":"4","author":"Geerlings","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"12","key":"10.1016\/j.sapharm.2026.06.009_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.009_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"issue":"639","key":"10.1016\/j.sapharm.2026.06.009_bib4","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.3399\/bjgp15X686965","article-title":"Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey","volume":"65","author":"Butler","year":"2015","journal-title":"Br J Gen Pract"},{"issue":"8","key":"10.1016\/j.sapharm.2026.06.009_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1294-5501(04)94270-7","article-title":"Prise en charge des infections urinaires communautaires dans les Service d'Accueil et d'Urgence Fran\u00e7ais","volume":"6","author":"Le Conte","year":"2004","journal-title":"Antibiotiques"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.009_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology Guidelines on Urological Infections: summary of the 2024 Guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.sapharm.2026.06.009_bib8","article-title":"Proposed guidelines on the evaluation of non-antibiotic versus antibiotic agents indicated for treatment of uncomplicated acute cystitis in adult female patients","volume":"14","author":"Naber","year":"2026","journal-title":"GMS Infect Dis"},{"key":"10.1016\/j.sapharm.2026.06.009_bib9","article-title":"Therapeutic strategies for uncomplicated cystitis in women","volume":"12","author":"Naber","year":"2024","journal-title":"GMS Infect Dis"},{"issue":"9","key":"10.1016\/j.sapharm.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10198-020-01222-8","article-title":"How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use","volume":"21","author":"Silhol","year":"2020","journal-title":"Eur J Health Econ"},{"issue":"2\u20133","key":"10.1016\/j.sapharm.2026.06.009_bib11","first-page":"121","article-title":"L\u2019acc\u00e8s aux soins de premier recours en Europe. \u00c9l\u00e9ments de pr\u00e9sentation","author":"Hartmann","year":"2006","journal-title":"Rev Fr Aff Soc"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sapharm.2016.01.002","article-title":"Pharmacist prescribing: a scoping review about the views and experiences of patients and the public","volume":"13","author":"Famiyeh","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.009_bib13","article-title":"The community pharmacist as an independent prescriber: a scoping review","volume":"64","author":"Piraux","year":"2024","journal-title":"J Am Pharmaceut Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.009_bib14","first-page":"179","article-title":"Community pharmacist prescribing of antimicrobials: a systematic review from an antimicrobial stewardship perspective","volume":"154","author":"Wu","year":"2021","journal-title":"Can Pharm J Rev Pharm Can"},{"issue":"5","key":"10.1016\/j.sapharm.2026.06.009_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.sapharm.2024.01.006","article-title":"The accessibility of pharmacist prescribing and impacts on medicines access: a systematic review","volume":"20","author":"Walpola","year":"2024","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.009_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pharmacy13060157","article-title":"Community pharmacist prescribing: roles and Competencies\u2014A systematic review and implications","volume":"13","author":"Clemens","year":"2025","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.009_bib17","first-page":"239","article-title":"De la territorialisation des pratiques de sant\u00e9 aux communaut\u00e9s professionnelles territoriales de sant\u00e9: Sant\u00e9 Publique","volume":"32","author":"De Fontgalland","year":"2020"},{"key":"10.1016\/j.sapharm.2026.06.009_bib18","article-title":"The construction of a territorial organization of primary care stakeholders facing the covid-19 epidemic: contributions of a case study at the canton level","author":"Fournier","year":"2021","journal-title":"Rev Francoph Sur Sant\u00e9 Territ"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s13063-024-08476-0","article-title":"Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst\u2019 protocol","volume":"25","author":"Piraux","year":"2024","journal-title":"Trials"},{"issue":"sep04 1","key":"10.1016\/j.sapharm.2026.06.009_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5661","article-title":"Consort 2010 statement: extension to cluster randomised trials","volume":"345","author":"Campbell","year":"2012","journal-title":"Br Med J"},{"key":"10.1016\/j.sapharm.2026.06.009_bib21","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"Br Med J"},{"key":"10.1016\/j.sapharm.2026.06.009_bib22","year":"2020","journal-title":"Code de la sant\u00e9 publique"},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.009_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000448591","article-title":"The acute cystitis symptom Score for patient-reported outcome assessment","volume":"97","author":"Alidjanov","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.sapharm.2026.06.009_bib24","article-title":"Additional assessment of Acute Cystitis Symptom Score questionnaire for patient-reported outcome measure in female patients with acute uncomplicated cystitis: part II","volume":"23","author":"Alidjanov","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.sapharm.2026.06.009_bib25","article-title":"Linguistic validation and cognitive assessment of the French version of the Acute Cystitis Symptom Score questionnaire","author":"Bruy\u00e8re","year":"2021","journal-title":"Prog Urol"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.009_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000356177","article-title":"New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute Cystitis symptom Score","volume":"92","author":"Alidjanov","year":"2014","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.009_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000493368","volume":"101","author":"Wagenlehner","year":"2018","journal-title":"Urol Int"},{"issue":"609","key":"10.1016\/j.sapharm.2026.06.009_bib28","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3399\/bjgp13X665206","article-title":"Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study","volume":"63","author":"Booth","year":"2013","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.sapharm.2026.06.009_bib29","first-page":"305","article-title":"Outcomes of Urinary Tract Infection Management by Pharmacists (R x OUTMAP): a study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community","volume":"151","author":"Beahm","year":"2018","journal-title":"Can Pharm J Rev Pharm Can"},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.009_bib30","first-page":"1","article-title":"Evaluating the management of urinary tract infections by community pharmacists in Queensland, Australia","volume":"22","author":"Spinks","year":"2024","journal-title":"Pharm Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.009_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.sapharm.2024.12.008","article-title":"Pharmacists as independent prescribers in community pharmacy: a scoping review","volume":"21","author":"Mesbahi","year":"2025","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.009_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s11096-023-01679-6","article-title":"The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review","volume":"46","author":"Swart","year":"2024","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2026.06.009_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/JCMA.0000000000000040","article-title":"The relationship of seasonality and the increase in urinary tract infections among hospitalized patients with spinal cord injury","volume":"82","author":"Hsu","year":"2019","journal-title":"J Chin Med Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.06.009_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jppr.1868","article-title":"Overview of factors influencing successful implementation of non\u2010medical prescribing","volume":"53","author":"Ghabour","year":"2023","journal-title":"J Pharm Pract Res"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.009_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052227","article-title":"Barriers and facilitators to implementation of non-medical independent prescribing in primary care in the UK: a qualitative systematic review","volume":"12","author":"Edwards","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2026.06.009_bib37","first-page":"20","article-title":"Independent pharmacist prescribers' views of their role as prescribers in primary care settings in Wales","volume":"28","author":"Alghamdi","year":"2020","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2026.06.009_bib38","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.sapharm.2021.07.015","article-title":"Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: a systematic review and meta-analysis","volume":"18","author":"Foot","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2026.06.009_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13827","article-title":"Pharmacist non\u2010medical prescribing in primary care. A systematic review of views, opinions, and attitudes","volume":"75","author":"Mills","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2026.06.009_bib40","first-page":"37","article-title":"Outpatient healthcare and clinical trials in the care pathway: organisational and regulatory aspects and tools","volume":"77","author":"Laviolle","year":"2022","journal-title":"Therapie (Paris)"},{"issue":"9","key":"10.1016\/j.sapharm.2026.06.009_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/antibiotics9090583","article-title":"Preventing and managing urinary tract infections: enhancing the role of community Pharmacists\u2014A mixed methods Study","volume":"9","author":"Peiffer-Smadja","year":"2020","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.sapharm.2026.06.009_bib42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.sapharm.2013.05.008","article-title":"Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists","volume":"10","author":"Pojskic","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"675","key":"10.1016\/j.sapharm.2026.06.009_bib43","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.3399\/bjgp18X699137","article-title":"Releasing GP capacity with pharmacy prescribing support and New Ways of Working: a prospective observational cohort study","volume":"68","author":"Maskrey","year":"2018","journal-title":"Br J Gen Pract"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:57Z","timestamp":1791221877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1551741126001592"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.06.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst\u2019 open-label, multicenter, randomized, controlled, cluster study","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}